Ultragenyx Pharmaceutical Inc. vs UnitedHealth Group Incorporated — Stock Comparison

RARE
Ultragenyx Pharmaceutical Inc.
$24.77
▲ 0.32%
vs
UNH
UnitedHealth Group Incorporated
$368.78
▼ 0.46%
Q·Score Winner
UnitedHealth Group Incorporated
UNH6.3/10vs 5.2/10

Q·Score Breakdown

5.2
Bearish
Overall
6.3
Neutral
0.2
Quality
6.2
5.9
Health
5.3
6.5
Growth
5.1
6.9
Valuation
7.3
8.6
Sentiment
8.1
RARE

90% of 20 covering analysts have a positive rating.

currently unprofitable (-85% margin).

UNH

82% of 28 covering analysts have a positive rating.

limited growth momentum.

Analyst Consensus

BUY
Target $53.35 (+115.4%)
20 analysts
BUY
Target $387.27 (+5.0%)
26 analysts

Fundamentals

RARE
UNH
Trailing P/E
27.9×
-1945.8×
Forward P/E
17.8×
-85.4%
Profit Margin
2.7%
-27.6%
Gross Margin
18.8%
-608.5%
ROE
12.2%
25.9%
Revenue Growth
2.0%
Earnings Growth
0.7%
0.25
Beta
0.41
Price / Book
$2.4B
Market Cap
$334.9B
$18 – $42
52-Week Range
$235 – $410

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →